-
ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM
18 Feb 2026 22:28 GMT
… : GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer … deeper and broader interest in HIV and AIDS than any company has …
-
UAB leads study to mitigate the medication adherence barriers in those living with HIV
19 Feb 2026 16:33 GMT
… outcomes. In infectious diseases like HIV, in addition to impacting individual … including populations representative of the HIV epidemic.
“This study enrolled … Houston McGovern School of Medicine. ViiV Healthcare and Johnson & Johnson provided …
-
Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership
26 Jan 2026 00:01 GMT
… exit their HIV-focused joint venture, ViiV Healthcare. The transaction values Pfizer’s exit … dividend as ViiV cancels Pfizer’s shares. GSK originally formed ViiV Healthcare with Pfizer in 2009 …
-
<![CDATA[Shionogi Acquires $2.1 Billion ViiV Healthcare Shareholdings from Pfizer ]]>
21 Jan 2026 02:09 GMT
… deeper and broader interest in HIV and AIDS while also taking a … Shionogi.
GSK, Pfizer and Shionogi Agree on Changes to ViiV Healthcare Shareholding ViiV Healthcare January 20 …
-
Heather contracted HIV on an overseas holiday. Women like her are more likely to be overlooked by doctors in Australia
09 Feb 2026 15:02 GMT
… predominant association of HIV with gay men – including among healthcare professionals – … Positive Action Community Grant from ViiV Healthcare, a pharmaceutical company specialising in … medicines to treat and prevent HIV/Aids.
Living in regional Victoria …
-
<![CDATA[HIV in the Black Community: Shifting from Stigma and Health Inequalities to Communication and Care Initiatives]]>
07 Feb 2026 16:00 GMT
… marks the annual National Black HIV/AIDS Awareness Day. This is … Partnerships at ViiV Healthcare.
Industry’s Role in Building Awareness
ViiV Healthcare has been … /156509
2.National Black HIV/AIDS Awareness Day. February 7 …
-
What will HIV funding look like in 2026?
07 Feb 2026 10:32 GMT
… monthly HIV prevention jab, lenacapavir, from the US government’s Aids … the Global Fund to Fight Aids, TB & Malaria.
By … from UNAids. Remember, World Aids Day data showed that from … think companies like ViiV and Gilead, which develop HIV drugs, shouldn’t …
-
At the foot of Mount Fuji, three champions carry Takaichi's ambition
19 Feb 2026 19:25 GMT
… driven by its HIV portfolio co-developed with ViiV Healthcare. In December 2025 …
-
GSK and Shionogi agree to replace Pfizer's stake in ViiV Healthcare
21 Jan 2026 07:55 GMT
… in ViiV Healthcare. Pfizer will receive $1.875 billion and GSK will … in GBP).
ViiV Healthcare, the global specialist HIV company, is dedicated … infectious diseases, with HIV being one of our … ongoing HIV research continues to contribute to ViiV’s pipeline …
-
GSK’s oncology and HIV drugs drive 7% sales rise in 2025
04 Feb 2026 19:33 GMT
… £554m in global sales.
GSK’ HIV portfolio was also a key … ) continued to be GSK’s best-selling HIV drug in 2025, … 4 February, the CEO of GSK-owned ViiV Healthcare, Deborah Waterhouse, noted that … opportunity” to GSK’s future presence in the HIV market.
Success …
About
© 1995-2026